Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco flag Morocco · Delayed Price · Currency is MAD
1,735.00
-4.00 (-0.23%)
At close: Feb 27, 2026
67.63%
Market Cap 13.20B
Revenue (ttm) 3.04B
Net Income (ttm) 345.28M
Shares Out 7.61M
EPS (ttm) 47.96
PE Ratio 36.83
Forward PE 33.30
Dividend 28.00 (1.61%)
Ex-Dividend Date Jun 20, 2025
Volume 365
Average Volume 572
Open 1,780.00
Previous Close 1,739.00
Day's Range 1,735.00 - 1,780.00
52-Week Range 990.00 - 1,950.00
Beta -0.19
RSI 43.26
Earnings Date Apr 21, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 1,219
Stock Exchange Casablanca Stock Exchange
Ticker Symbol SOT
Full Company Profile

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.

Financial Statements

News

There is no news available yet.